Literature DB >> 10326289

Plague.

R W Titball1, S E Leary.   

Abstract

Yersinia pestis, the aetiological agent of plague, has in the past caused social devastation on a scale unmatched by other infectious diseases. There is still a public health problem from plague, with at least 2000 cases reported annually. Most of these cases are of the bubonic form. Occasionally bubonic plague develops into pneumonic plague, and this form of the disease can spread rapidly between susceptible individuals. The recent outbreak of plague in India highlighted the potential for plague to explosively re-appear, and modern mass transport systems mean that there is the potential for the rapid spread of disease. Against this background, there is a need to ensure that vaccines and antibiotics are available to prevent and treat the disease. Progress has been made in devising a sub-unit vaccine, effective against bubonic and pneumonic plague. Antibiotics must be given in the early stages of disease to effect a cure.

Entities:  

Mesh:

Year:  1998        PMID: 10326289     DOI: 10.1093/oxfordjournals.bmb.a011715

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


  14 in total

Review 1.  Use of aminoglycosides in treatment of infections due to intracellular bacteria.

Authors:  M Maurin; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

2.  Structure of the cytoplasmic domain of Yersinia pestis YscD, an essential component of the type III secretion system.

Authors:  George T Lountos; Joseph E Tropea; David S Waugh
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2012-02-07

3.  Oxime-based click chemistry in the development of 3-isoxazolecarboxylic acid containing inhibitors of Yersinia pestis protein tyrosine phosphatase, YopH.

Authors:  Medhanit Bahta; Terrence R Burke
Journal:  ChemMedChem       Date:  2011-06-10       Impact factor: 3.466

Review 4.  Two decades of plant-based candidate vaccines: a review of the chimeric protein approaches.

Authors:  Ruth Elena Soria-Guerra; Leticia Moreno-Fierros; Sergio Rosales-Mendoza
Journal:  Plant Cell Rep       Date:  2011-04-20       Impact factor: 4.570

5.  Structure of the Yersinia pestis FabV enoyl-ACP reductase and its interaction with two 2-pyridone inhibitors.

Authors:  Maria W Hirschbeck; Jochen Kuper; Hao Lu; Nina Liu; Carla Neckles; Sonam Shah; Steffen Wagner; Christoph A Sotriffer; Peter J Tonge; Caroline Kisker
Journal:  Structure       Date:  2012-01-11       Impact factor: 5.006

6.  Utilization of nitrophenylphosphates and oxime-based ligation for the development of nanomolar affinity inhibitors of the Yersinia pestis outer protein H (YopH) phosphatase.

Authors:  Medhanit Bahta; George T Lountos; Beverly Dyas; Sung-Eun Kim; Robert G Ulrich; David S Waugh; Terrence R Burke
Journal:  J Med Chem       Date:  2011-03-28       Impact factor: 7.446

7.  Protection against pneumonic plague following oral immunization with a non-replicating vaccine.

Authors:  Abby Jones; Catharine Bosio; Angela Duffy; Andrew Goodyear; Martin Schriefer; Steven Dow
Journal:  Vaccine       Date:  2010-06-19       Impact factor: 3.641

8.  Pathogenesis of Yersinia pestis infection in BALB/c mice: effects on host macrophages and neutrophils.

Authors:  Roman A Lukaszewski; Dermot J Kenny; Rosa Taylor; D G Cerys Rees; M Gill Hartley; Petra C F Oyston
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

9.  Genome-level transcription data of Yersinia pestis analyzed with a new metabolic constraint-based approach.

Authors:  Ali Navid; Eivind Almaas
Journal:  BMC Syst Biol       Date:  2012-12-06

10.  Characterization of new substrates targeted by Yersinia tyrosine phosphatase YopH.

Authors:  María Luisa de la Puerta; Antonio G Trinidad; María del Carmen Rodríguez; Jori Bogetz; Mariano Sánchez Crespo; Tomas Mustelin; Andrés Alonso; Yolanda Bayón
Journal:  PLoS One       Date:  2009-02-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.